Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

by Collantes Maria, Peñuelas Ivan, Catena Raul, Redrado Miriam, Manrique Irene, Perez-Stable Carlos, Parrondo Ricardo, Nguewa Paul A, Diaz Roque, Díaz-González Juan, Calvo Alfonso
Published 2010-05-01